Valuation: M3, Inc.

Market Cap 1,261B 7.99B 7.17B 6.62B 6B 11.22B 759B 11.36B 79.36B 31.52B 398B 29.98B 29.34B P/E 2027 *
24.5x
P/E 2028 * 21.9x
Enterprise Value 1,121B 7.1B 6.37B 5.88B 5.33B 9.97B 674B 10.09B 70.52B 28.01B 353B 26.64B 26.07B EV / Sales 2027 *
2.89x
EV / Sales 2028 * 2.58x
Free-Float
61.47%
Yield 2027 *
1.22%
Yield 2028 * 1.34%
1 day-1.50%
1 week-0.50%
Current month+7.23%
1 month+6.46%
3 months+2.42%
6 months+26.71%
Current year-10.96%
1 week 5.76
Extreme 5.7601
6.4
1 month 5.36
Extreme 5.3647
6.4
Current year 3.97
Extreme 3.97
7.08
1 year 3.97
Extreme 3.97
8.85
3 years 3.79
Extreme 3.79
8.85
5 years 3.79
Extreme 3.79
29.91
10 years 3.79
Extreme 3.79
52.42
Manager TitleAgeSince
President 61 29/09/2000
Investor Relations Contact 46 -
Corporate Officer/Principal - -
Director TitleAgeSince
Director/Board Member 61 29/09/2000
Director/Board Member 54 01/06/2012
Director/Board Member 61 01/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-0.50% - - 7.99B
+1.19%-5.79%+19.06%+162.40% 3,900B
-1.64%-10.67%-17.40%+109.01% 1,585B
-0.59%-1.70%+6.55%+67.50% 534B
+0.62%-1.57%-39.91%+31.21% 442B
-2.16%-8.98%-42.88%+57.14% 257B
-0.01%-7.71%-44.14%+21.03% 249B
-1.41%-4.42%-5.28%+257.35% 213B
-0.53%-4.58%-31.78%+59.54% 134B
-2.95%+5.58%-15.56%+248.57% 114B
Average -0.19%-4.93%-19.04%+112.64% 825.44B
Weighted average by Cap. +0.89%-6.50%+0.46%+130.20%

Financials

2027 *2028 *
Net sales 388B 2.46B 2.21B 2.04B 1.85B 3.45B 234B 3.5B 24.43B 9.7B 122B 9.23B 9.03B 424B 2.69B 2.41B 2.23B 2.02B 3.77B 255B 3.82B 26.68B 10.59B 134B 10.08B 9.86B
Net income 51.03B 323M 290M 268M 243M 454M 30.7B 460M 3.21B 1.28B 16.09B 1.21B 1.19B 57B 361M 324M 299M 271M 507M 34.29B 513M 3.59B 1.42B 17.98B 1.36B 1.33B
Net Debt -141B -890M -799M -738M -669M -1.25B -84.54B -1.27B -8.84B -3.51B -44.31B -3.34B -3.27B -168B -1.07B -957M -883M -801M -1.5B -101B -1.52B -10.59B -4.21B -53.08B -4B -3.92B
Projected Income Statement - Annual - M3, Inc.
Logo M3, Inc.
M3 Inc is a Japan-based company mainly engaged in the provision of services centering on the platform of healthcare. The Company has five business segments. Medical Platforms segment conducts marketing-related businesses in Japan utilizing the Internet and real operations centered on medical employee specialized site m3.com. Evidence Solution segment is engaged in the contract research organization (CRO) business that supports clinical development work and research, and site management organization (SMO) business that manages the clinical trial operations. Career Solutions segment is engaged in human resource services for healthcare professionals. Site Solution segment provides operational support for medical institutions and home-visit nursing services. Overseas segment provides services of medical related marketing support, research and careers, utilizing the medical employee specialized sites in the United States, the United Kingdom, China, Korea, India, France, Germany and Spain.
Employees
17,010
Date Price Change Volume
27/10/26 US$5.930 -1.50% 49,149
26/10/26 US$6.020 +0.33% 83,412
23/10/26 US$6.000 -2.44% 52,077
22/10/26 US$6.150 +1.82% 143,227
21/10/26 US$6.040 +1.34% 155,129
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - M3, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
1,889.50JPY
Average target price
1,973.33JPY
Spread / Average Target
+4.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - M3, Inc.